C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/40 (2006.01) C07K 16/00 (2006.01) C07K 16/12 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2045150
2045150 9106305 PCTABS00005 Novel oligomeric monoclonal antibodies with high avidity for antigen are described. The oligomers, typically of the IgG class, are secreted having two or more immunoglobulin monomers associated together to form tetravalent or hexavalent IgG molecules. The oligomers can be formed by substantially duplicating regions of the light chain, particularly the variable region. Oligomeric antibodies of the IgG isotype cross the placenta and can provide passive immunity to a fetus, which is particularly important for protecting newborns against pathogens such as group B streptococci.
Harris Linda J.
Raff Howard V.
Shuford Walt W.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Oligomeric immunoglobulins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligomeric immunoglobulins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligomeric immunoglobulins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1695856